Glaxosmithkline Phar Latest News

  1. Pursuant to clause 33 of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on Friday...

    Date:28-12-2017
  2. Glaxosmithkline Pharmaceuticals has informed that the in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from Monda...

    Date:28-12-2017
  3. Total income of the company increased by 3.51% at Rs 845.87 crore for Q2FY18
    Date:26-10-2017
  4. Total income of the company increased by 3.51% at Rs 845.87 crore for Q2FY18
    Date:26-10-2017
  5. The board of directors at its meeting held on September 22, 2017 has approved for the same
    Date:25-09-2017
  6. The board of directors at its meeting held on September 22, 2017 has approved for the same
    Date:25-09-2017
  7. Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, the Schedule of Analyst or Institutional Meet...

    Date:18-08-2017
  8. GlaxoSmithKline Pharmaceuticals has informed about the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.

    The above information is a part of...

    Date:26-07-2017
  9. Total income of the company decreased by 14.89% at Rs 620.75 crore for Q1FY18
    Date:26-07-2017
  10. Glaxosmithkline Pharmaceuticals has informed about Un-Audited Standalone Financial Results for first quarter ended June 30, 2017.

    The above information is a part of company...

    Date:25-07-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
 
 
Request a Call Back
Mobile
Invalid Mobile Number
x
Thanks. We will call you shortly.